These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2482977)

  • 1. Hydroxyurea-induced switching of hemoglobin proportions toward newborn values in normal adult rats is blocked by acetylsalicylic acid.
    Datta MC; Dowla HA; Spears HJ
    Prog Clin Biol Res; 1989; 319():651-60; discussion 661. PubMed ID: 2482977
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin blocks 5-azacytidine- and hydroxyurea-induced changes in hemoglobin proportions in adult rats.
    Datta MC; Dowla HA; Srivastava KK; Boswell VD; Washington I
    Eur J Pharmacol; 1991 Feb; 193(2):173-7. PubMed ID: 1710991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between plasma PGE2 level and changes in hemoglobin proportions during bleeding-induced anemia in adult rats.
    Datta MC; Spears HJ; Dowla HA
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1017-25. PubMed ID: 3480706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylsalicylic acid antagonizes the bleeding-induced changes in hemoglobin proportions in normal adult rats.
    Datta MC; Josephs J; Tolbert ME; Anderson J; Dowla H
    Biochem Biophys Res Commun; 1986 May; 137(1):69-75. PubMed ID: 2424450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin switching: a new animal model for genetic and molecular studies.
    Tam JW; Hui CC; Woo C; Lam VM
    Birth Defects Orig Artic Ser; 1987; 23(5A):133-7. PubMed ID: 2446673
    [No Abstract]   [Full Text] [Related]  

  • 7. Embryogenic effect on post-natal changes in hemoglobin concentration with time.
    Kahn AJ
    Growth; 1968 Mar; 32(1):13-22. PubMed ID: 5658995
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of mouse hemoglobin expression by hydroxyurea and erythropoietin in vivo.
    Alter BP; Wagner CK; Susser LS; Weinberg RS
    Prog Clin Biol Res; 1989; 316B():317-25. PubMed ID: 2616578
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the hemoglobin content of the erythrocytes in white rats in ontogeny].
    Nazarov SB; Kozinets GI
    Biull Eksp Biol Med; 1992 Jul; 114(8):143-5. PubMed ID: 1467474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E; Inusa B
    Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin switching and its clinical implications.
    Blau CA; Stamatoyannopoulos G
    Curr Opin Hematol; 1994 Mar; 1(2):136-42. PubMed ID: 9371272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative aspects of developmental haemoglobins in ruminants.
    Ranjekar PK; Barnabas J
    Indian J Biochem; 1969 Mar; 6(1):1-5. PubMed ID: 4257190
    [No Abstract]   [Full Text] [Related]  

  • 13. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome.
    Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP;
    Br J Haematol; 2005 Nov; 131(3):378-88. PubMed ID: 16225658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell pain & hydroxyurea.
    Day SW; Wynn LW
    Am J Nurs; 2000 Nov; 100(11):34-8; quiz 38-9. PubMed ID: 11103633
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase of fetal hemoglobin synthesis indicating differentiation induction in children receiving valproic acid.
    Kieslich M; Schwabe D; Cinatl J; Driever PH
    Pediatr Hematol Oncol; 2003; 20(1):15-22. PubMed ID: 12687749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of fetal hemoglobin in anemic monkeys by myleran.
    Liang CC; Liu DP; Jia PC; Ao ZH; Chen SS; Yang KG
    Prog Clin Biol Res; 1987; 251():467-78. PubMed ID: 2448814
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic hemoglobin reversal: the importance of lipid intermediaries and the proposed involvement of the cAMP and phosphatidylinositol second messenger systems.
    Pearson JT; Critz W; McKell D; Enriquez J; Gregory G; Brady K; Baker T; Casey T
    Hemoglobin; 1998 May; 22(3):245-61. PubMed ID: 9629499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of eterilate, benorylate and acetylsalicylic acid on blood glucose in normal and experimentally diabetic rats].
    Alonso S; Ortega MP; Armijo M
    Arch Farmacol Toxicol; 1983 Aug; 9(2):183-90. PubMed ID: 6140900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.